Tolerance to the cereal disease Fusarium crown rot (FCR) was investigated in a set of 34 durum wheat genotypes, with Suntop, (bread wheat) and EGA Bellaroi (durum) as tolerant and intolerant controls, in a series of replicated field trials over four years with inoculated (FCR-i) and non-inoculated (FCR-n) plots of the genotypes. The genotypes included conventional durum lines and lines derived from crossing durum with 2-49, a bread wheat genotype with the highest level of partial resistance to FCR. A split plot trial design was chosen to optimize the efficiency for the prediction of FCR tolerance for each genotype. A multi-environment trial (MET) analysis was undertaken which indicated that there was good repeatability of FCR tolerance across years. Based on an FCR tolerance index, Suntop was the most tolerant genotype and EGA Bellaroi was very intolerant, but some durum wheats had FCR tolerance indices which were comparable to Suntop. These included some conventional durum genotypes, V101030, TD1702, V11TD013*3X-63 and DBA Bindaroi, as well as genotypes from crosses with 2-49 (V114916 and V114942). The correlation between FCR tolerance and FCR-n yield predictions was moderately negative indicating it could be somewhat difficult to develop FCR-tolerant genotypes that are high yielding under low disease pressure. However, FCR tolerance showed a positive correlation with FCR-i yield predictions in seasons of high disease expression indicating it could be possible to screen for FCR tolerance using only FCR-i treatments. These results are the first demonstration of genetic diversity in durum germplasm for FCR tolerance and they provide a basis for breeding for this trait.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880437 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240766 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
TaWRKY24 integrates the tryptophan metabolism pathways to participate in defense against Fusarium crown rot in wheat.
Plant J
December 2024
State Key Laboratory of Crop Gene Resources and Breeding, Institute of Crop Sciences, Chinese Academy of Agricultural Sciences (CAAS), Beijing, China.
Wheat growth process has been experiencing severe challenges arising from the adverse environment. Notably, the incidence of Fusarium crown rot (FCR), a severe soil-borne disease caused by Fusarium pseudograminearum (Fp), has significantly intensified in various wheat-growing regions, resulting in a decline in grain yield. However, the identification of wheat varieties and the exploration of effective gene resources resistant to FCR have not yet been accomplished.
View Article and Find Full Text PDFMetabolism of Roots Provides Insights into Iron Deficiency Tolerance Mechanisms.
Plants (Basel)
September 2024
College of Horticulture, Gansu Agricultural University, Lanzhou 730070, China.
Iron (Fe) deficiency is one of the most common micronutrient imbalances limiting plant growth globally, especially in arid and saline alkali regions due to the decreased availability of Fe in alkaline soils. grows well in arid regions and is tolerant of Fe deficiency. Here, a physiological and metabolomic approach was used to analyze the short-term molecular response of roots to Fe deficiency.
View Article and Find Full Text PDFFunctional Identification of MhPYL4 Involved in Iron-Deficiency Stress in Malus Halliana Koehne.
Plants (Basel)
August 2024
College of Horticulture, Gansu Agricultural University, Lanzhou 730070, China.
The PYL protein family are crucial sensors of the core signals of abscisic acid (ABA) and significantly influence the plant's response to ABA-mediated abiotic stresses as well as its growth and development. However, research on the role of the gene in iron (Fe) deficiency in apple trees is limited. Studies have shown that the gene, when exposed to Fe-deficiency stress, exhibits more rapid transcriptional upregulation than other genes' quickly elevated transcription.
View Article and Find Full Text PDFTeplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes.
J Clin Invest
August 2024
Departments of Immunobiology and Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Article Synopsis
- - Teplizumab is an approved treatment for delaying type 1 diabetes (T1D) in patients at risk, with recent studies revealing that 36% of participants were either undiagnosed or remained diabetes-free after 5 years, indicating potential operational tolerance.
- - Analysis of CD8+ T cells showed initial activation signs post-treatment, which reverted after 18 months, with reduced gene expression linked to T cell response in those who responded positively to the drug while showing increased exhaustion markers.
- - The study concluded that teplizumab helps promote operational tolerance in T1D by inducing T cell exhaustion and preventing the growth of autoantigen-reactive T cells over time.
Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia.
Bone Marrow Transplant
September 2024
Vanderbilt University Medical Center, Department of Pharmaceutical Services, Nashville, TN, USA.
The age effect in severe aplastic anemia (SAA) following allogeneic hematopoietic cell transplantation (HCT) favors the use of reduced intensity conditioning (RIC) regimens in older adults. We implemented a non-myeloablative regimen consisting of fludarabine, cyclophosphamide, and rituximab (FCR) to improve HCT outcomes in SAA. Patients who underwent first HCT for SAA utilizing an FCR regimen between January 2016 and May 2022 were included.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!